https://www.selleckchem.com/pr....oducts/8-cyclopentyl
Mean follow-up after discharge was similar (11±5.3 vs. 10.9±5.5 months, p=0.81). The protocol-based follow-up program was associated with a significant reduction in all-cause readmission (26% vs. 60%, p=0.003), heart failure readmission (16% vs. 36%, p=0.032), and mortality (4% vs. 20%, p=0.044). In the study group there was a significant improvement in all quality of life measures (p less then 0.001). CONCLUSION A protocol-based follow-up program for patients with heart failure led to a significant reduction
Beğen
Yorum Yap
Paylaş
